NCT00476177View on ClinicalTrials.gov

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2007

Study Completion Date

July 31, 2009

Conditions
Hematologic Malignancy
Interventions
BIOLOGICAL

Infusion of donor dendritic cells

Given in the outpatient setting

BIOLOGICAL

Infusion of donor lymphocytes

Given in outpatient setting

Trial Locations (2)

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00476177 - Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant | Biotech Hunter | Biotech Hunter